Mostly the gut, mostly early. The nausea is the same mechanism as the effect, felt as a symptom.
The common adverse effects of GLP‑1 medicines are gastrointestinal, and they follow from how the medicines work rather than being incidental to it. These drugs slow stomach emptying and act on brain regions involved in appetite and nausea. Slower emptying and reduced appetite are the intended effects; nausea is the same mechanism felt as a symptom.
This page describes what is reported and how it is managed clinically. It is not instructions, and nothing here should be used to adjust a prescription.
From the trial data and product information for this class:
Most are mild to moderate and settle. They are also the main reason people discontinue, which is why the titration schedule exists.
Every agent in this class starts well below its therapeutic dose and increases in steps over weeks. That schedule is not caution for its own sake — it is the single most effective tool for limiting side effects, by letting the gut adapt between increases.
Going up faster than the schedule reliably produces more nausea. Where someone is struggling, holding at the current dose for longer before the next step is a standard clinical response, and a dose reduction is another. Both are decisions for the prescriber.
The usual clinical measures, described here so you know what to expect from a competent prescriber rather than so you can self‑manage:
A short list, and the reason a prescription without follow‑up is inadequate:
Anaesthesia. Delayed gastric emptying means the stomach may not be empty after a standard fast. Anaesthesia bodies have issued guidance on this and recommendations have evolved. Tell any anaesthetist or surgeon that you are taking one of these, well before a procedure. It is the single most important practical point on this page.
Other medicines. Slower emptying can affect how other oral drugs are absorbed. Worth a specific conversation if you take anything where timing matters.
Rapid weight loss from any cause includes lean tissue as well as fat. The proportion varies, and losing muscle matters because it lowers resting energy expenditure — which is part of why weight returns when treatment stops.
Protein intake and resistance training during treatment are the standard countermeasures. A clinic that prescribes and does not raise this is managing a number rather than a person.
None of this tells you whether to start, continue or stop anything. Side effects are a conversation with the prescriber who wrote the prescription — which presumes there is one, that they are contactable, and that follow‑up was part of what you were sold.
Every patient starts the same way: thirty minutes with a physician, then a full biomarker panel drawn at a laboratory near you. Whether any medicine follows is your doctor’s decision, made after reading your results with you.
Measure my biomarkers